health
IP Watch | 28-Apr-2017
Although Canada won in a unanimous decision, the ruling does not, however, guarantee domestic discretion going forward, contrary to the suggestion of some.
Global Justice Now | 24-Apr-2017
A new briefing has outlined the likely elements of a UK-US trade deal and argues that it would contain more extreme forms of all the controversial elements of the deal that was being negotiated between the EU and the USA.
Tech Dirt | 21-Apr-2017
ISDS is an attempt to remove the risk of investment from companies, and place it squarely on the public’s shoulders, without any quid pro quo.
Public Citizen | 1-Apr-2017
Novartis battle against Colombian Government highlights the threats to public health posed by the outrageous investor-state dispute settlement regime and bad “trade” deals.
Tech Dirt | 22-Mar-2017
Just the fact that the Canadian government had to go through this massive and expensive process for many years just for rejecting two bad patents should show why ISDS provisions are such a problem.
Politico | 20-Mar-2017
Canada has prevailed over pharmaceutical giant Eli Lilly in a long-running investor-state dispute the drug company filed under NAFTA’s investment chapter.
IELP Blog | 12-Mar-2017
A dissent sends the message: beware, if one other arbitrator had gone the way that Born did, we would have won.
The Australian | 2-Mar-2017
Taxpayers are still in the dark about how much of their money has been spent on fighting tobacco giant Philip Morris over plain packaging laws.
The Tyee | 28-Feb-2017
FIPA means province could be blocked from improving care standards for residents.
Prensa Latina | 27-Dec-2016
El triunfo del Gobierno de Uruguay ante la demanda establecida por la tabacalera transnacional Philip Morris constituyó en el año que termina un fuerte espaldarazo a las autoridades del pequeño país sudamericano en su campaña contra el tabaquismo.